Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-15
DOI
10.1038/s41467-022-34346-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy
- (2021) Xiaoli Hu et al. MOLECULAR THERAPY
- Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
- (2021) Xiaoming Dai et al. MOLECULAR CELL
- ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
- (2021) Youqian Wu et al. Nature Communications
- TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
- (2021) Zexian Zeng et al. NUCLEIC ACIDS RESEARCH
- The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
- (2021) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage
- (2021) Sarmishtha De et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor
- (2020) Chengcheng Guan et al. Nature Communications
- Integrated Proteomic and N-Glycoproteomic Analyses of Human Breast Cancer
- (2020) Zhiyuan Wang et al. JOURNAL OF PROTEOME RESEARCH
- Quality Control of ER Membrane Proteins by the RNF185/Membralin Ubiquitin Ligase Complex
- (2020) Michael L. van de Weijer et al. MOLECULAR CELL
- The Ins and Outs of HOPS/TMUB1 in biology and pathology
- (2020) Maria Agnese Della Fazia et al. FEBS Journal
- Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
- (2020) Yang Gao et al. NATURE CELL BIOLOGY
- PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
- (2020) Junwei Hou et al. NATURE CELL BIOLOGY
- Global view of human protein glycosylation pathways and functions
- (2020) Katrine T. Schjoldager et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- HOPS/Tmub1 involvement in the NF-kB-mediated inflammatory response through the modulation of TRAF6
- (2020) Marina Maria Bellet et al. Cell Death & Disease
- Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
- (2020) Dan Zhu et al. CELL DEATH AND DIFFERENTIATION
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
- (2019) Han Yao et al. Nature Biomedical Engineering
- Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
- (2019) Heng-Huan Lee et al. CANCER CELL
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- Drugging K-RasG12C through covalent inhibitors: Mission possible?
- (2019) Duan Ni et al. PHARMACOLOGY & THERAPEUTICS
- HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53‐dependent mitochondrial apoptosis
- (2019) Marilena Castelli et al. EMBO REPORTS
- Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer
- (2019) Jianchun Duan et al. JAMA Oncology
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Quality Control in the Endoplasmic Reticulum: Crosstalk between ERAD and UPR pathways
- (2018) Jiwon Hwang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
- (2018) Xian Shen et al. BMJ-British Medical Journal
- Palmitoylation stabilizes PD-L1 to promote breast tumor growth
- (2018) Yi Yang et al. CELL RESEARCH
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial Carcinoma
- (2017) Guru Sonpavde NEW ENGLAND JOURNAL OF MEDICINE
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice
- (2017) Janet Lau et al. Nature Communications
- Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on Monoubiquitinaton
- (2017) Henrick Horita et al. NEOPLASIA
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Spatiotemporal Regulation of a Legionella pneumophila T4SS Substrate by the Metaeffector SidJ
- (2015) Kwang Cheol Jeong et al. PLoS Pathogens
- Ubiquitination in disease pathogenesis and treatment
- (2014) Doris Popovic et al. NATURE MEDICINE
- Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19Arf network
- (2012) M Castelli et al. ONCOGENE
- Membrane-associated Ubiquitin Ligase Complex Containing gp78 Mediates Sterol-accelerated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase
- (2011) Youngah Jo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase
- (2010) Youngah Jo et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
- (2009) Q. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started